Drugs / Prismocitrate 18
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05399537 | Jul 2024 → Dec 2026 expected | acute kidney injury | Vantive Health LLC | Recruiting | No outcome recorded |
| Phase 3 | NCT02860130 | Sep 2016 → May 2018 | acute kidney injury | Vantive Health LLC | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prismocitrate 18 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05399537 ↗ |